190
Participants
Start Date
December 7, 2022
Primary Completion Date
January 4, 2024
Study Completion Date
March 3, 2024
GN-037
GN-037
Clobetasol 17-propionate
Clobetasol 17-propionate
Placebo
Placebo
Istanbul University Cerrahpasa Faculty of Medicine, Istanbul
Erciyes University Faculty of Medicine, Kayseri
Ankara Etlik City Hospital, Ankara
Balıkesir University Faculty of Medicine, Balıkesir
Uludag University Faculty of Medicine, Bursa
Pamukkale University Faculty of Medicine, Denizli
Ataturk University Research Hospital, Erzurum
Basaksehir Cam and Sakura City Hospital, Istanbul
Bezmialem Vakif University Faculty of Medicine, Istanbul
Haydarpasa Numune Training and Research Hospital, Istanbul
Istanbul Haseki Training and Research Hospital, Istanbul
Istanbul University Istanbul Faculty of Medicine, Istanbul
University of Health Sciences Bakırkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul
İzmir Democracy University Buca Seyfi Demirsoy Training And Research Hospital, Izmir
Necmettin Erbakan University Meram Faculty of Medicine, Konya
Mersin University Faculty of Medicine, Mersin
Samsun Ondokuz Mayis University Faculty of Medicine, Samsun
Uşak Training and Research Hospital, Uşak
Collaborators (1)
Monitor CRO
INDUSTRY
GEN İlaç ve Sağlık Ürünleri A.Ş.
INDUSTRY